JPRN-UMIN000008764尚未招募2 期
A phase II trial of pemetrexed/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. - A phase II trial of pemetrexed/bevacizumab in elderly patients with advanced NSCLC.
Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School0 个研究点目标入组 36 人开始时间: 2012年8月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) history of hemoptysis (more than 2.5mL) 2) with pulmonary cavitary lesions 3) with invasion to the aorta and/or pulmonary arteries 4) tumor outcrop in main bronchus 5) history of radical thoracic radiotherapy 6) patients treated by anti-coagulation therapy complicated with brain metastasis 7) with severe infection 8) with massive pleural effusion, ascites or pericardial effusion 9) overlapped with other malignancies 10) with severe peptic ulcer 11) history of perforation in digestive tract
研究者
相似试验
招募中
2 期
A Phase II study of Pemetrexed/Bevacizumab in patients ineligible for platinum-based chemotherapy with untreated Advanced Non-squamous non-small-cell lung cancer (ALCT003)on-squamous Non-small cell lung cancerJPRN-UMIN000010805Department of Respiratory Medicine Kyorin Univercity Hospital25
已完成
2 期
Phase II study of Bevacizumab + Pemetrexed in elderly patients with advanced non-squamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000010733Central Japan Lung Study Group37
招募中
2 期
Phase II Study of Pemetrexed+Bevacizumab for previously untreated elderly patients with nonsquamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000008781Toho university medical center sakura hospital25
招募中
2 期
A phase II study of Bevacizumab plus Pemetrexed for previously treated Non Small Cell Lung Cancer with T790M mutatioon-small cell lung cancerJPRN-UMIN000008032Toho University Omori Medical Center15
已完成
2 期
Phase II study of Pemetrexed and Bevacizumab in Plutinum Unfit patients with untreated advanced non-squamous non-small cell lung cancer(OSAKA-LCSG1201)non-small cell lung cancerJPRN-UMIN000009539OSAKA-LCSG45